[india-drug] ARV white list

["Dr.Thatte" <mthatte@vsnl.com>]

ARV white list
--------------


The move of the WHO to publish an ARV white list is welcome. We in
India must also make attempts to develop a "white list" and share the
experiences of procurement agencies to reduce the burden of inspections
and improve the quality of drugs.


Dr. Urmila Thatte
Dept. of Clinical Pharmacology
BYL Nair Hospital
Mumbai 400 008
Tel: 91 22 305 0347; 301 4713;=20
         91 22 308 1490 ext 205
Fax : 91 22 307 5243
e-mail: clinpharm@vsnl

(As suggested by Dr. Leela McCullough, Director of Information
Services, Satellife, Boston, the issues like- What are the 
steps needed to create the white list for India? Where will the 
information come from?-- are to be dealt with because the electronic
discussion group is an ideal medium for the collection and compilation
of material.----Sunitha)


________________________________________________________________________
For live cricket scores download  Yahoo! Score Tracker
 at: http://in.sports.yahoo.com/cricket/tracker.html
The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@usa.healthnet.org